Increased VAP-1 immunoreactivity has been demonstrated in microvessels in human conjunctival tumors [31] and in human breast cancer, tumor VAP-1 mRNA expression is associated with oestrogen receptor expression and improved prognosis [32, 33]. This evidence concerns the gene AOC3 and neoplasm.